4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000033
Director disposed of 13,367,481 shares (other)
- Director returned 523,926 shares (to the company)
- Director acquired 8,230,453 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
NARINE JEENARINE · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-04-25 | Returned to the company : show line 1 in the form | −150,000 | $0.08 | $12,000 | 16,412,461 | I |
| 2013-04-26 | Returned to the company : show line 2 in the form | −243,926 | $0.08 | $19,563 | 16,168,535 | I |
| 2013-04-26 | Conversion : show line 3 in the form | +8,230,453 | 24,398,988 | I | ||
| 2013-04-29 | Returned to the company : show line 4 in the form | −130,000 | $0.08 | $10,400 | 24,268,988 | I |
| 2013-04-29 | Other disposition : show line 5 in the form | −13,367,481 | $0.04 | $493,260 | 15,357,334 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-04-26 | Conversion : show line 6 in the form Series E Convertible Preferred Stock | −200 | $1,000.00 | $200,000 | 1,600 | I |
| 2013-04-26 | Other disposition : show line 7 in the form Warrants | −13,272,999 | 26,727,001 | I |
Loading xslF345X03/primary_doc.xml…